Variant report
Variant | nsv470945 |
---|---|
Chromosome Location | chr10:56795078-56849669 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534474913 | chr10:56799021-56799022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs181853726 | chr10:56799029-56799030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530280695 | chr10:56799171-56799172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs11004696 | chr10:56799192-56799193 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs74136333 | chr10:56799193-56799194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs532847202 | chr10:56799225-56799226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552281818 | chr10:56799232-56799233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs190703873 | chr10:56799235-56799236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs146936540 | chr10:56799317-56799318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs2178646 | chr10:56799334-56799335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs114486722 | chr10:56799345-56799346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs533721003 | chr10:56799365-56799366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553936526 | chr10:56799374-56799375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541223067 | chr10:56807802-56807803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs186903454 | chr10:56807846-56807847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs192109813 | chr10:56807855-56807856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs550063360 | chr10:56807907-56807908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569987053 | chr10:56807986-56807987 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs201354665 | chr10:56808027-56808028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs72801621 | chr10:56808057-56808058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs548713873 | chr10:56808134-56808135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs202134629 | chr10:56808145-56808146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565759947 | chr10:56808215-56808216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs534468290 | chr10:56808228-56808229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs185014993 | chr10:56808235-56808236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190209947 | chr10:56808248-56808249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs193147814 | chr10:56808255-56808256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs185596723 | chr10:56808263-56808264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs573788310 | chr10:56808264-56808265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs576667772 | chr10:56808322-56808323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs542196781 | chr10:56808342-56808343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188416946 | chr10:56808365-56808366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572480045 | chr10:56808480-56808481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs180734434 | chr10:56808484-56808485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs55742901 | chr10:56808501-56808502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564584349 | chr10:56808562-56808563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577882030 | chr10:56808563-56808564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs185776014 | chr10:56808617-56808618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs563557088 | chr10:56808623-56808624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs529215210 | chr10:56808695-56808696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs548963025 | chr10:56808804-56808805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs10763176 | chr10:56808806-56808807 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs528161665 | chr10:56808832-56808833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs562245115 | chr10:56808848-56808849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs368189109 | chr10:56808858-56808859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs10825449 | chr10:56808870-56808871 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs571031435 | chr10:56808895-56808896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs539598952 | chr10:56808961-56808962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs117723843 | chr10:56808967-56808968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570324844 | chr10:56808980-56808981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
small cell lung cancer | 17426248 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:56799000-56799400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr10:56807800-56809400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
3 | chr10:56808200-56809200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr10:56808400-56809200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr10:56808400-56809400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr10:56808600-56809200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr10:56808800-56809200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr10:56808800-56809200 | Enhancers | Brain Germinal Matrix | brain |
9 | chr10:56809000-56809200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
10 | chr10:56824000-56825800 | Enhancers | HepG2 | liver |
11 | chr10:56840400-56841000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
12 | chr10:56840800-56841200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
13 | chr10:56841000-56841200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
14 | chr10:56841200-56849000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr10:56847200-56847600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
16 | chr10:56849000-56849200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
17 | chr10:56849000-56849200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
18 | chr10:56849200-56849400 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |